Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eur J Cancer Care (Engl) ; 31(6): e13649, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35781903

ABSTRACT

OBJECTIVE: Ovarian cancer has the highest mortality of all gynaecological cancers. This study aimed to identify the extent to which women across New South Wales experienced variation in their care in diagnosis and initial treatment for ovarian cancer against the national optimal care pathway for ovarian cancer. METHOD: Clinical audit methodology was utilised to explore variations for women with primary ovarian cancer; 171 eligible cases were identified through by the NSW Cancer Registry for the period of 1 March 2017 to 28 February 2018. RESULTS: Limited variation was detected with 86% of women being reviewed by a specialist gynaecological oncology multidisciplinary team; 54% of women received their first treatment within 28 days of their first specialist appointment, 66% of women having their first surgery completed by a gynaecological oncologist and 45% of women received their first treatment in a specialist gynaecological oncology hospital. CONCLUSION: Deviation from effective ovarian cancer care is apparent particularly in the location and timeliness of first treatment, with implications for the quality of care received and care outcomes. Understanding factors that contribute to variation is critical to ensure optimal and appropriate ovarian cancer care and to tackle systemic barriers to the provision of effective care.


Subject(s)
Genital Neoplasms, Female , Ovarian Neoplasms , Female , Humans , New South Wales , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/therapy , Genital Neoplasms, Female/therapy , Australia , Clinical Audit
2.
BMC Health Serv Res ; 21(1): 1044, 2021 Oct 02.
Article in English | MEDLINE | ID: mdl-34600507

ABSTRACT

BACKGROUND: Multidisciplinary cancer care to facilitate the provision of patient centred and evidence-based care is considered best practice internationally. In 2016 multidisciplinary care measures were developed for all local health districts across NSW. The aim of this study was to identify system-level changes and quality improvement activities across the NSW cancer system linked to reporting on these measures. METHODS: Focus group discussions were used to generate a synergy of ideas from key stakeholders. An exploratory descriptive approach was used within the ontological position of Framework Analysis, the analysis method chosen for this research study, sitting most closely within pragmatism. The use of Framework Analysis in the analytic strategy is because it is well-suited to addressing policy issues and maintaining specific focus within a wider dataset. RESULTS: Two focus groups were held with a total of 18 purposively selected participants. Four primary themes emerged: value of electronic documentation; role clarity; relationships; and future development of measures. Key findings included that the reporting of performance measures has expedited the development of electronic documentation and data extraction from the multidisciplinary team meeting (MDT), identified barriers and facilitators to MDT data collection and supported MDT improvement activities across NSW. CONCLUSIONS: The findings of this study have highlighted that MDTs and their meetings across NSW are harnessing technological advancements to support and further develop their MDTs, as well as the challenges of implementing new processes within the MDTM. This study adds a unique contribution to knowledge of how the reporting of measures can assist in understanding variation in the development and implementation of multidisciplinary teams, as well as highlighting future programs of work to decrease variation in multidisciplinary team meetings and quality improvement activities.


Subject(s)
Neoplasms , Australia , Data Collection , Focus Groups , Humans , Neoplasms/therapy , New South Wales , Patient Care Team
3.
Aust N Z J Obstet Gynaecol ; 60(4): 592-597, 2020 08.
Article in English | MEDLINE | ID: mdl-32458415

ABSTRACT

BACKGROUND: Little is known about the delivery of surgical services and outcomes for women with ovarian cancer across New South Wales (NSW). AIM: The study objective was to provide a descriptive analysis of the proportion of women who had surgery for ovarian cancer in NSW in specialist gynaecological oncology hospitals and compare outcomes for women attending specialist and non-specialist services in NSW. MATERIALS AND METHODS: This study is a retrospective analysis of women with primary ovarian, fallopian tube or peritoneal cancer from 2009 to 2012. Data were analysed from the NSW Cancer Registry, NSW Admitted Patient Data Collection and Register of Births Deaths and Marriages. Treating hospitals were characterised as public specialist, public non-specialist and private. Morbidity and mortality outcomes are reported. RESULTS: The study included 1106 women. Fifty-seven hospitals performed surgery: seven public specialist, 27 private and 23 public non-specialist hospitals. The highest proportion of surgery was performed in public specialist hospitals (61%). There was considerable variation in the utilisation of public specialist hospitals between local health districts. There was no significant difference in outcomes related to the type of hospital where surgery was performed. CONCLUSIONS: Although the majority of women are having surgery in a specialist gynaecological oncology public hospital across NSW, many are not. Women living in regional and remote NSW were less likely to have their surgery in a specialist hospital. This is the first step in understanding where women in NSW are currently receiving their surgical care, as well as the outcomes related to this.


Subject(s)
Ovarian Neoplasms , Female , Hospitals, Public , Humans , New South Wales/epidemiology , Ovarian Neoplasms/surgery , Pregnancy , Retrospective Studies
4.
BMC Public Health ; 19(1): 296, 2019 Mar 12.
Article in English | MEDLINE | ID: mdl-30866891

ABSTRACT

BACKGROUND: Clinical variation in ovarian cancer care has been reported internationally. Using Wennberg's classification of clinical variation as effective care we can conceptualise variation through deviation from clinical guidelines. The aim of this review was to address knowledge gaps in the effectiveness of attempts to reduce unwarranted clinical variation through addressing the following questions: What is the evidence of guideline adherence in ovarian cancer and its deviation?; what are the key factors associated with variation in guideline adherence in ovarian cancer care?; and what quality improvement approaches have been used and what is the evidence of their effectiveness in enhancing guideline adherence in ovarian cancer care?. METHODS: Keywords and synonyms for the major concepts of ovarian cancer, guideline adherence and safety were developed and combined to form the search strategy. Systematic searches of four electronic databases were undertaken of publications from January 2007 to November 2018. Retrieved articles were assessed against the eligibility criteria to determine those for inclusion. RESULTS: Thirty-two papers were included in the review with three broad groupings identified: adherence to and deviation from guidelines (either local, national or international guidelines); factors impacting guidelines adherence; and quality improvement approaches. CONCLUSIONS: Unwarranted clinical variation may be used as a marker for the effectiveness of a health system, based on the outcome of this systematic review. This review found that the implementation of quality indicators through a formal quality improvement program lead to improvements in guideline adherent care. Further research on outcomes of implementing quality improvement programs in ovarian cancer care will improve the ability to implement centralised care and further identify factors that to improve outcomes in ovarian cancer care.


Subject(s)
Guideline Adherence/statistics & numerical data , Ovarian Neoplasms/therapy , Practice Guidelines as Topic , Quality Improvement , Female , Humans
5.
BMC Palliat Care ; 18(1): 4, 2019 Jan 10.
Article in English | MEDLINE | ID: mdl-30630479

ABSTRACT

BACKGROUND: The aim of the study was to assess four evidence-based assessments utilising exercise challenges that induce breathlessness, each with progressively less demanding levels of exertion, which can be tailored to people with a range of functional capabilities in the setting of advanced cancer for research studies. Functional cut off points for these assessments have not previously been defined. METHODS: A cross sectional study of four exercise tests attempted by all participants: 6 min walk test (6MWT); (derived) 2 min walk test (2MWT); arm exercises; and reading numbers aloud. Performance status (Australia-modified Karnofsky Performance Status (AKPS)), baseline breathlessness using the modified Medical Research Council (mMRC) breathlessness scale, and a visual analogue scale of intensity and unpleasantness of breathlessness were measured. Co-morbidity was codified using the Charlson Co-morbidity Index. Percentage of people completing each test by AKPS level of function and baseline mMRC breathlessness scores were quantified. RESULTS: In the 68 participants, poorer function decreased the proportion of people able to complete the exercise tests. For completion rates ≥80%, of 6MWT and 2MWT, only people with an AKPS 70-90 had completion. For arm exercises, this included people with an AKPS as low as ≥50; and for reading numbers, it included people with an AKPS of 40 but not below. CONCLUSIONS: Walking tests have poor utility in people with high levels of functional impairment. For people with high levels of dependence, reading numbers should be used in evaluating exercise-induced breathlessness in research studies. These data also suggest that people's exertional limitations have been under-estimated as cancer progresses.


Subject(s)
Dyspnea/physiopathology , Neoplasms/complications , Physical Functional Performance , Adult , Aged , Aged, 80 and over , Australia , Cohort Studies , Cross-Sectional Studies , Exercise Test/methods , Female , Humans , Male , Middle Aged , Neoplasms/physiopathology , Physical Exertion/physiology
6.
Public Health Res Pract ; 33(3)2023 Sep 13.
Article in English | MEDLINE | ID: mdl-36792351

ABSTRACT

OBJECTIVE: Gaps and complexities exist in cancer referral and diagnosis in Australia, leading to delays in cancer treatments. Developing evidence-based referral pathways is important for promoting better and more timely cancer diagnosis and care. Type of program or service: This paper describes a toolkit endorsed by the Cancer Institute NSW as a guide for promoting best practice in localising cancer referral and diagnosis pathways in line with the national Optimal Care Pathways. Use of toolkit: Employing methods in the toolkit yielded an increased understanding of cancer care pathways, strengthened collaboration between tertiary and primary sector stakeholders, and enhanced the project skills of Cancer System Innovation Managers. The toolkit has become a valuable guide for consolidating referral pathways for various cancers in the NSW local health districts and could apply to cancer services in other jurisdictions. LESSONS LEARNT: The pilot project showed that the toolkit is useful in developing referral pathways and reflects best stakeholder engagement practices. Local evidence should be generated to support systematic change and should include the perspectives of cancer patients and clinicians. NSW local health districts continue to use the toolkit methods to optimise care to improve outcomes for people living with cancer.


Subject(s)
Critical Pathways , Neoplasms , Humans , Pilot Projects , Australia , Neoplasms/diagnosis , Neoplasms/therapy
7.
BMJ Open ; 7(12): e018629, 2017 12 28.
Article in English | MEDLINE | ID: mdl-29288182

ABSTRACT

OBJECTIVES: Few interventions have been designed that provide standardised information to primary care clinicians about the diagnostic and treatment recommendations resulting from cancer multidisciplinary team (MDT) (tumour board) meetings. This study aimed to develop, implement and evaluate a standardised template for lung cancer MDTs to provide clinical information and treatment recommendations to general practitioners (GPs). Specific objectives were to (1) evaluate template feasibility (acceptability, appropriateness and timeliness) with GPs and (2) document processes of preimplementation, implementation and evaluation within the MDT setting. DESIGN: A mixed-method study design using structured interviews with GPs and qualitative documentation of project logs about implementation processes. SETTING: Two hospitals in Central Sydney, New South Wales, Australia. PARTICIPANTS: 61 GPs evaluated the template. Two lung cancer MDTs, consisting of 33 clinicians, and eight researchers participated in template development and implementation strategy. RESULTS: The MDT-reporting template appears to be a feasible way of providing clinical information to GPs following patient presentation at a lung cancer MDT meeting. Ninety-five per cent of GPs strongly agreed or agreed that the standardised template provided useful and relevant information, that it was received in a timely manner (90%) and that the information was easy to interpret and communicate to the patient (84%). Implementation process data show that the investment made in the preimplementation stage to integrate the template into standard work practices was a critical factor in successful implementation. CONCLUSIONS: This study demonstrates that it is feasible to provide lung cancer MDT treatment recommendations to GPs through implementation of a standardised template. A simple intervention, such as a standardised template, can help to address quality gaps and ensure that timely information is communicated between tertiary and primary care healthcare providers.


Subject(s)
Documentation/standards , General Practitioners , Interdisciplinary Communication , Lung Neoplasms/therapy , Patient Care Team/organization & administration , Quality Assurance, Health Care/standards , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , New South Wales , Surveys and Questionnaires , Young Adult
8.
Transl Lung Cancer Res ; 5(3): 244-6, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27413702

ABSTRACT

This paper aims to explore the vital role occupational therapists play in enabling people living with lung cancer to continue to actively live. Core assessments and interventions employed by occupational therapists are described in a case study. It will demonstrate how people living with lung cancer can continue to participate in meaningful and chosen life roles, even in the face of functional decline. Skilled management by the occupational therapist of the refractory symptoms of advanced lung cancer supports this participation.

9.
Curr Opin Support Palliat Care ; 6(2): 138-43, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22498835

ABSTRACT

PURPOSE OF REVIEW: This review aims to define and explore the contribution of occupational therapy in end-of-life care, with a particular focus on breathlessness. It examines occupational therapy interventions for the management of breathlessness and makes recommendations for future research. RECENT FINDINGS: An emerging body of research demonstrates people with advanced disease continue to strive for active participation in everyday activities in the face of debilitating symptoms such as breathlessness. It is through active participation that people adjust to bodily decline. When specific everyday activities are targeted for intervention, implantation of strategies to manage breathlessness within the context of these activities has been found to optimize function and well being for those with chronic obstructive pulmonary disease. Evidence examining the efficacy of energy conservation and relaxation is limited and requires more robust examination. SUMMARY: Symptoms such as dyspnoea need to be considered within the contexts in which they exist - that is, the bodily experience of breathlessness and its impact on everyday activities or occupations. The clinical and theoretical focus of occupational therapy supports the enablement of continued participation in valued and essential activities and offers a unique focal point for research. Emerging research demonstrates the importance of translating the benefits of effective symptom management into everyday activities and informs a future research agenda.


Subject(s)
Dyspnea/rehabilitation , Occupational Therapy/methods , Terminal Care/methods , Dyspnea/physiopathology , Energy Metabolism , Humans , Relaxation Therapy
SELECTION OF CITATIONS
SEARCH DETAIL